

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | iron ion import (GO:0097286) | 8.20126225 |
| 2 | artery development (GO:0060840) | 7.46948146 |
| 3 | biotin metabolic process (GO:0006768) | 7.44802064 |
| 4 | protein autoprocessing (GO:0016540) | 7.30494909 |
| 5 | prostate gland epithelium morphogenesis (GO:0060740) | 6.78405272 |
| 6 | positive regulation of macrophage cytokine production (GO:0060907) | 6.75373192 |
| 7 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 6.65085094 |
| 8 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 6.58158366 |
| 9 | opsonization (GO:0008228) | 6.39830934 |
| 10 | neurofilament cytoskeleton organization (GO:0060052) | 6.38421866 |
| 11 | epithelial cell maturation (GO:0002070) | 6.36800744 |
| 12 | regulation of receptor binding (GO:1900120) | 6.28547589 |
| 13 | positive regulation of steroid hormone secretion (GO:2000833) | 6.05892709 |
| 14 | import into cell (GO:0098657) | 5.87651405 |
| 15 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.85551478 |
| 16 | endothelial cell chemotaxis (GO:0035767) | 5.80802735 |
| 17 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 5.59687204 |
| 18 | mitotic cell cycle arrest (GO:0071850) | 5.34309361 |
| 19 | intestinal epithelial cell development (GO:0060576) | 5.33324244 |
| 20 | adaptation of signaling pathway (GO:0023058) | 5.24646764 |
| 21 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.16772375 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15076344 |
| 23 | carnitine shuttle (GO:0006853) | 5.13983093 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 5.10493269 |
| 25 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 5.08219058 |
| 26 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 5.04582137 |
| 27 | pharyngeal system development (GO:0060037) | 4.84663284 |
| 28 | detection of temperature stimulus (GO:0016048) | 4.83653811 |
| 29 | response to peptidoglycan (GO:0032494) | 4.75186758 |
| 30 | response to testosterone (GO:0033574) | 4.61277036 |
| 31 | lung epithelial cell differentiation (GO:0060487) | 4.58929130 |
| 32 | positive regulation of cellular amine metabolic process (GO:0033240) | 4.56280724 |
| 33 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.55761256 |
| 34 | regulation of macrophage cytokine production (GO:0010935) | 4.54444325 |
| 35 | thioester biosynthetic process (GO:0035384) | 4.49264111 |
| 36 | acyl-CoA biosynthetic process (GO:0071616) | 4.49264111 |
| 37 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.48866196 |
| 38 | granulocyte activation (GO:0036230) | 4.47943829 |
| 39 | acetyl-CoA metabolic process (GO:0006084) | 4.47334047 |
| 40 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.45682993 |
| 41 | lung cell differentiation (GO:0060479) | 4.45384907 |
| 42 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.38198488 |
| 43 | neutrophil activation (GO:0042119) | 4.33497366 |
| 44 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.33029785 |
| 45 | respiratory burst (GO:0045730) | 4.28576252 |
| 46 | linoleic acid metabolic process (GO:0043651) | 4.27809074 |
| 47 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.27459347 |
| 48 | superoxide anion generation (GO:0042554) | 4.26963727 |
| 49 | carnitine transmembrane transport (GO:1902603) | 4.24266469 |
| 50 | regulation of protein polyubiquitination (GO:1902914) | 4.19897926 |
| 51 | regulation of viral entry into host cell (GO:0046596) | 4.19326286 |
| 52 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 4.08369984 |
| 53 | fatty acid transmembrane transport (GO:1902001) | 4.04889879 |
| 54 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 4.03834831 |
| 55 | desmosome organization (GO:0002934) | 4.00384694 |
| 56 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.99748352 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.90736577 |
| 58 | reactive oxygen species biosynthetic process (GO:1903409) | 3.89360152 |
| 59 | regulation of platelet aggregation (GO:0090330) | 3.86894355 |
| 60 | regulation of steroid hormone secretion (GO:2000831) | 3.86253941 |
| 61 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.84096012 |
| 62 | carnitine transport (GO:0015879) | 3.81559579 |
| 63 | amino-acid betaine transport (GO:0015838) | 3.81559579 |
| 64 | protein homotrimerization (GO:0070207) | 3.79371393 |
| 65 | toxin transport (GO:1901998) | 3.78356233 |
| 66 | cellular response to interferon-alpha (GO:0035457) | 3.73495786 |
| 67 | lung lobe morphogenesis (GO:0060463) | 3.67673052 |
| 68 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.67095237 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 3.66867321 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66197127 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66197127 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 3.66197127 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66197127 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 3.66197127 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66197127 |
| 76 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.65872795 |
| 77 | coenzyme A biosynthetic process (GO:0015937) | 3.64904048 |
| 78 | regulation of microtubule-based movement (GO:0060632) | 3.61765557 |
| 79 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.59192352 |
| 80 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.57535646 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57319046 |
| 82 | positive regulation of heat generation (GO:0031652) | 3.56082135 |
| 83 | retinal metabolic process (GO:0042574) | 3.55058520 |
| 84 | regulation of fever generation (GO:0031620) | 3.54142175 |
| 85 | glandular epithelial cell differentiation (GO:0002067) | 3.52760507 |
| 86 | Golgi to endosome transport (GO:0006895) | 3.49797584 |
| 87 | leukocyte aggregation (GO:0070486) | 3.49297690 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47761886 |
| 89 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.41585115 |
| 90 | positive regulation of chemokine secretion (GO:0090197) | 3.41515413 |
| 91 | androgen receptor signaling pathway (GO:0030521) | 3.40877386 |
| 92 | hemidesmosome assembly (GO:0031581) | 3.40721337 |
| 93 | regulation of activation of Janus kinase activity (GO:0010533) | 3.39465342 |
| 94 | apical protein localization (GO:0045176) | 3.38348212 |
| 95 | quaternary ammonium group transport (GO:0015697) | 3.36748897 |
| 96 | phospholipid scrambling (GO:0017121) | 3.35370120 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.34853518 |
| 98 | regulation of monocyte chemotaxis (GO:0090025) | 3.34503762 |
| 99 | monocyte chemotaxis (GO:0002548) | 3.33832556 |
| 100 | myeloid leukocyte mediated immunity (GO:0002444) | 3.33048851 |
| 101 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.32054406 |
| 102 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.30257629 |
| 103 | lung secretory cell differentiation (GO:0061140) | 3.29763469 |
| 104 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.29200269 |
| 105 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.27710119 |
| 106 | positive regulation of type 2 immune response (GO:0002830) | 3.24257488 |
| 107 | positive regulation of mast cell degranulation (GO:0043306) | 3.22556882 |
| 108 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.22556882 |
| 109 | regulation of ARF protein signal transduction (GO:0032012) | 3.22271194 |
| 110 | coenzyme A metabolic process (GO:0015936) | 3.21372814 |
| 111 | establishment of skin barrier (GO:0061436) | 3.21131054 |
| 112 | regulation of chemokine biosynthetic process (GO:0045073) | 3.20491725 |
| 113 | COPII vesicle coating (GO:0048208) | 3.20378114 |
| 114 | negative regulation of DNA repair (GO:0045738) | 3.17882320 |
| 115 | mitochondrion degradation (GO:0000422) | 3.15799258 |
| 116 | regulation of chemokine secretion (GO:0090196) | 3.13396064 |
| 117 | regulation of hypersensitivity (GO:0002883) | 3.09930027 |
| 118 | type I interferon signaling pathway (GO:0060337) | 3.09904420 |
| 119 | cellular response to type I interferon (GO:0071357) | 3.09904420 |
| 120 | cellular response to nicotine (GO:0071316) | 3.08331999 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07842404 |
| 122 | response to type I interferon (GO:0034340) | 3.07148815 |
| 123 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.05577664 |
| 124 | macrophage activation involved in immune response (GO:0002281) | 3.03956142 |
| 125 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.03008159 |
| 126 | copper ion transport (GO:0006825) | 3.00030744 |
| 127 | pantothenate metabolic process (GO:0015939) | 2.99055100 |
| 128 | regulation of actin nucleation (GO:0051125) | 2.98559747 |
| 129 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97627330 |
| 130 | response to host immune response (GO:0052572) | 2.97627330 |
| 131 | corticosteroid receptor signaling pathway (GO:0031958) | 2.97065569 |
| 132 | Golgi transport vesicle coating (GO:0048200) | 2.96134185 |
| 133 | COPI coating of Golgi vesicle (GO:0048205) | 2.96134185 |
| 134 | natural killer cell mediated immunity (GO:0002228) | 2.94174913 |
| 135 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.94174913 |
| 136 | glomerular visceral epithelial cell development (GO:0072015) | 2.93751662 |
| 137 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.92471456 |
| 138 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.92471456 |
| 139 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.92471456 |
| 140 | leukocyte mediated cytotoxicity (GO:0001909) | 2.92249524 |
| 141 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92143810 |
| 142 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.91873824 |
| 143 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.91767525 |
| 144 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91364934 |
| 145 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.90865146 |
| 146 | detection of other organism (GO:0098543) | 2.90663139 |
| 147 | regulation of water loss via skin (GO:0033561) | 2.89797822 |
| 148 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.88708192 |
| 149 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.87504413 |
| 150 | detection of bacterium (GO:0016045) | 2.86876317 |
| 151 | negative regulation of stress fiber assembly (GO:0051497) | 2.85716288 |
| 152 | dorsal/ventral neural tube patterning (GO:0021904) | 2.85679183 |
| 153 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.84974473 |
| 154 | positive regulation of response to nutrient levels (GO:0032109) | 2.84974473 |
| 155 | positive regulation of interferon-alpha production (GO:0032727) | 2.83989847 |
| 156 | piRNA metabolic process (GO:0034587) | 2.82578288 |
| 157 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.82345953 |
| 158 | fructose metabolic process (GO:0006000) | 2.81858171 |
| 159 | axon development (GO:0061564) | 2.79479169 |
| 160 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.79063037 |
| 161 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78758416 |
| 162 | regulation of RIG-I signaling pathway (GO:0039535) | 2.77553084 |
| 163 | myelin maintenance (GO:0043217) | 2.76410554 |
| 164 | neuronal action potential (GO:0019228) | 2.76148633 |
| 165 | peripheral nervous system neuron development (GO:0048935) | 2.76147416 |
| 166 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.76015998 |
| 167 | positive regulation of mast cell activation (GO:0033005) | 2.75848630 |
| 168 | negative regulation of fatty acid transport (GO:2000192) | 2.75799536 |
| 169 | behavioral response to pain (GO:0048266) | 2.75610435 |
| 170 | myeloid cell activation involved in immune response (GO:0002275) | 2.73483628 |
| 171 | regulation of platelet activation (GO:0010543) | 2.73186930 |
| 172 | T-helper 1 type immune response (GO:0042088) | 2.73121155 |
| 173 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73052575 |
| 174 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.68258057 |
| 175 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.67442702 |
| 176 | regulation of heat generation (GO:0031650) | 2.67342756 |
| 177 | regulation of interferon-alpha production (GO:0032647) | 2.66389636 |
| 178 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.64764233 |
| 179 | molting cycle (GO:0042303) | 2.64737878 |
| 180 | hair cycle (GO:0042633) | 2.64737878 |
| 181 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.63901667 |
| 182 | intermediate filament organization (GO:0045109) | 2.63892589 |
| 183 | response to interferon-alpha (GO:0035455) | 2.63541658 |
| 184 | neutrophil mediated immunity (GO:0002446) | 2.63416444 |
| 185 | positive regulation of acute inflammatory response (GO:0002675) | 2.62746387 |
| 186 | regulation of histone phosphorylation (GO:0033127) | 2.60590548 |
| 187 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60514218 |
| 188 | response to ATP (GO:0033198) | 2.58667049 |
| 189 | eosinophil chemotaxis (GO:0048245) | 2.56148158 |
| 190 | lymphocyte mediated immunity (GO:0002449) | 2.55053138 |
| 191 | superoxide metabolic process (GO:0006801) | 2.54787850 |
| 192 | positive regulation of interleukin-6 production (GO:0032755) | 2.54714768 |
| 193 | phagosome maturation (GO:0090382) | 2.53427412 |
| 194 | response to muramyl dipeptide (GO:0032495) | 2.52912803 |
| 195 | B cell mediated immunity (GO:0019724) | 2.51736236 |
| 196 | cellular response to zinc ion (GO:0071294) | 2.51346696 |
| 197 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.51150688 |
| 198 | positive regulation of interleukin-17 production (GO:0032740) | 2.51109368 |
| 199 | branching involved in prostate gland morphogenesis (GO:0060442) | 10.7967942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 6.58356316 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.54396805 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.17767171 |
| 4 | AR_21909140_ChIP-Seq_LNCAP_Human | 5.78975051 |
| 5 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 5.62656598 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.57306471 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.48168848 |
| 8 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 4.31804608 |
| 9 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 3.80039620 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.58814460 |
| 11 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 3.14774679 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99512816 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.74556519 |
| 14 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.66585682 |
| 15 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.64120460 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62543556 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.58525182 |
| 18 | CHD1_26751641_Chip-Seq_LNCaP_Human | 2.55205514 |
| 19 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.54512519 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.43322369 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42738328 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.40537535 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37432471 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24647074 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15869681 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14896506 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.13889098 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97894819 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96057551 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92438513 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85203337 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.85148306 |
| 33 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.84686686 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84281021 |
| 35 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.82408468 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.78016842 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.76873043 |
| 38 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76497742 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69542431 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64828372 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64685840 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63047878 |
| 43 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.60281647 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59982180 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59436409 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57627659 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55622981 |
| 48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54751223 |
| 49 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.54135996 |
| 50 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.54135996 |
| 51 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.54135996 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53450376 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.51612521 |
| 54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51492010 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50474992 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.49353506 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47818765 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47626631 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44684948 |
| 60 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.44546703 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.40609933 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40235412 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.37909579 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37906670 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37272056 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.37179605 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36711789 |
| 68 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36505206 |
| 69 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.35198422 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32194931 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.31338474 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28727591 |
| 73 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.26385535 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25834964 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24292868 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23493917 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23493917 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21885822 |
| 79 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.21876044 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20863176 |
| 81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19135220 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18849421 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18261418 |
| 84 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17896296 |
| 85 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16134532 |
| 86 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16134532 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15280873 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14971816 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11720606 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11664905 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10556717 |
| 92 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.10432373 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09120531 |
| 94 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08418227 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06933486 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06569051 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06143219 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06047311 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05201460 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04571278 |
| 101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04318988 |
| 102 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.04102296 |
| 103 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03863607 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03324600 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02500060 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02467802 |
| 107 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.01877426 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01551665 |
| 109 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01532342 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01272448 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99497114 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97838586 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97725589 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97317242 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96914262 |
| 116 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96862834 |
| 117 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96443314 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94729044 |
| 119 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93441284 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92533962 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92274763 |
| 122 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90879642 |
| 123 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.90681976 |
| 124 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90599884 |
| 125 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.90149598 |
| 126 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89636964 |
| 127 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89241579 |
| 128 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88999035 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88915529 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88887841 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88665127 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86194127 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84873003 |
| 134 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84398230 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84298105 |
| 136 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83431417 |
| 137 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83191318 |
| 138 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83125264 |
| 139 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.82727499 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82413664 |
| 141 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82039399 |
| 142 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81391090 |
| 143 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80371532 |
| 144 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80189959 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80076566 |
| 146 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78722981 |
| 147 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78714117 |
| 148 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78710800 |
| 149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78668459 |
| 150 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78209231 |
| 151 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.78019330 |
| 152 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77837264 |
| 153 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77394845 |
| 154 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76755959 |
| 155 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76601682 |
| 156 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.76432496 |
| 157 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.75758562 |
| 158 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75120416 |
| 159 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75028888 |
| 160 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.74942450 |
| 161 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.73679829 |
| 162 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73579599 |
| 163 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73394323 |
| 164 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.72832616 |
| 165 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72459662 |
| 166 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72296183 |
| 167 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.72005589 |
| 168 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71658986 |
| 169 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71632017 |
| 170 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71328904 |
| 171 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.71097365 |
| 172 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.68835560 |
| 173 | KDM2B_26808549_Chip-Seq_REH_Human | 0.68099027 |
| 174 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.67973036 |
| 175 | P300_19829295_ChIP-Seq_ESCs_Human | 0.67734138 |
| 176 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.66874352 |
| 177 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.66515579 |
| 178 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.66340076 |
| 179 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.66120552 |
| 180 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65675283 |
| 181 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65459853 |
| 182 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.65387588 |
| 183 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.65049723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 5.54361202 |
| 2 | MP0000537_abnormal_urethra_morphology | 4.63896051 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 4.07192421 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.93115525 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.84761603 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.75797307 |
| 7 | MP0002736_abnormal_nociception_after | 3.63408994 |
| 8 | MP0002822_catalepsy | 3.62816573 |
| 9 | MP0003011_delayed_dark_adaptation | 3.55280727 |
| 10 | MP0009785_altered_susceptibility_to | 3.40006403 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.36437608 |
| 12 | MP0001835_abnormal_antigen_presentation | 3.32880600 |
| 13 | MP0003315_abnormal_perineum_morphology | 3.32455075 |
| 14 | MP0003436_decreased_susceptibility_to | 3.21392076 |
| 15 | MP0003724_increased_susceptibility_to | 3.19832515 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.93989093 |
| 17 | MP0005647_abnormal_sex_gland | 2.74819875 |
| 18 | MP0002234_abnormal_pharynx_morphology | 2.72532340 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.72079603 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.67158084 |
| 21 | MP0004947_skin_inflammation | 2.55209829 |
| 22 | MP0002419_abnormal_innate_immunity | 2.50836038 |
| 23 | MP0001873_stomach_inflammation | 2.50000001 |
| 24 | MP0005025_abnormal_response_to | 2.39552629 |
| 25 | MP0000579_abnormal_nail_morphology | 2.38874997 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 2.37812694 |
| 27 | MP0006082_CNS_inflammation | 2.32187325 |
| 28 | MP0002796_impaired_skin_barrier | 2.17729045 |
| 29 | MP0002254_reproductive_system_inflammat | 2.13124742 |
| 30 | MP0004858_abnormal_nervous_system | 2.10878060 |
| 31 | MP0005367_renal/urinary_system_phenotyp | 2.07533242 |
| 32 | MP0000516_abnormal_urinary_system | 2.07533242 |
| 33 | MP0009764_decreased_sensitivity_to | 2.02468104 |
| 34 | MP0005671_abnormal_response_to | 1.96267874 |
| 35 | MP0005387_immune_system_phenotype | 1.95620902 |
| 36 | MP0001790_abnormal_immune_system | 1.95620902 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.93474206 |
| 38 | MP0003303_peritoneal_inflammation | 1.93333360 |
| 39 | MP0008260_abnormal_autophagy | 1.87060630 |
| 40 | MP0000383_abnormal_hair_follicle | 1.86184287 |
| 41 | MP0002723_abnormal_immune_serum | 1.81166059 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.79970419 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.76222446 |
| 44 | MP0001800_abnormal_humoral_immune | 1.74367613 |
| 45 | MP0004381_abnormal_hair_follicle | 1.74131282 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.73756536 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.71919499 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.70059111 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.69857126 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.69701479 |
| 51 | MP0000685_abnormal_immune_system | 1.68712064 |
| 52 | MP0005670_abnormal_white_adipose | 1.68040025 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.67180644 |
| 54 | MP0010771_integument_phenotype | 1.66881157 |
| 55 | MP0000613_abnormal_salivary_gland | 1.65704982 |
| 56 | MP0003283_abnormal_digestive_organ | 1.65523756 |
| 57 | MP0002006_tumorigenesis | 1.60970290 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.60640702 |
| 59 | MP0003075_altered_response_to | 1.58300088 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.56509878 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.55799950 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.54285476 |
| 63 | MP0001216_abnormal_epidermal_layer | 1.54040101 |
| 64 | MP0005451_abnormal_body_composition | 1.50752994 |
| 65 | MP0000858_altered_metastatic_potential | 1.49053064 |
| 66 | MP0001819_abnormal_immune_cell | 1.48550999 |
| 67 | MP0010678_abnormal_skin_adnexa | 1.48183106 |
| 68 | MP0001970_abnormal_pain_threshold | 1.46208793 |
| 69 | MP0001664_abnormal_digestion | 1.46193048 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 1.44871318 |
| 71 | MP0001756_abnormal_urination | 1.44866642 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 1.44440102 |
| 73 | MP0003941_abnormal_skin_development | 1.44407381 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.43892179 |
| 75 | MP0004510_myositis | 1.43665211 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.42658427 |
| 77 | MP0000427_abnormal_hair_cycle | 1.38557635 |
| 78 | MP0005275_abnormal_skin_tensile | 1.35416426 |
| 79 | MP0009278_abnormal_bone_marrow | 1.35185733 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 1.29403510 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.28812243 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.27388114 |
| 83 | MP0004043_abnormal_pH_regulation | 1.25988124 |
| 84 | MP0002060_abnormal_skin_morphology | 1.25235350 |
| 85 | MP0002405_respiratory_system_inflammati | 1.24959429 |
| 86 | MP0001853_heart_inflammation | 1.22876244 |
| 87 | MP0005166_decreased_susceptibility_to | 1.22326209 |
| 88 | MP0001765_abnormal_ion_homeostasis | 1.21025699 |
| 89 | MP0000647_abnormal_sebaceous_gland | 1.20982848 |
| 90 | MP0003195_calcinosis | 1.20444332 |
| 91 | MP0003448_altered_tumor_morphology | 1.19892049 |
| 92 | MP0003879_abnormal_hair_cell | 1.18132845 |
| 93 | MP0001919_abnormal_reproductive_system | 1.13644336 |
| 94 | MP0008469_abnormal_protein_level | 1.13079803 |
| 95 | MP0000343_altered_response_to | 1.12581683 |
| 96 | MP0001851_eye_inflammation | 1.12466348 |
| 97 | MP0003566_abnormal_cell_adhesion | 1.12340172 |
| 98 | MP0000538_abnormal_urinary_bladder | 1.12203416 |
| 99 | MP0002693_abnormal_pancreas_physiology | 1.10951500 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.10695617 |
| 101 | MP0005501_abnormal_skin_physiology | 1.07311600 |
| 102 | MP0000462_abnormal_digestive_system | 1.06344471 |
| 103 | MP0001764_abnormal_homeostasis | 1.05703225 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 1.05552146 |
| 105 | MP0005310_abnormal_salivary_gland | 1.04670272 |
| 106 | MP0000372_irregular_coat_pigmentation | 1.03102318 |
| 107 | MP0005187_abnormal_penis_morphology | 1.01960432 |
| 108 | MP0000534_abnormal_ureter_morphology | 0.99823166 |
| 109 | MP0000377_abnormal_hair_follicle | 0.98664835 |
| 110 | MP0000604_amyloidosis | 0.97182072 |
| 111 | MP0003705_abnormal_hypodermis_morpholog | 0.96621940 |
| 112 | MP0003186_abnormal_redox_activity | 0.95826049 |
| 113 | MP0010386_abnormal_urinary_bladder | 0.94027751 |
| 114 | MP0005390_skeleton_phenotype | 0.93542595 |
| 115 | MP0001191_abnormal_skin_condition | 0.92624314 |
| 116 | MP0001501_abnormal_sleep_pattern | 0.91235108 |
| 117 | MP0005164_abnormal_response_to | 0.89511671 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.89479655 |
| 119 | MP0006276_abnormal_autonomic_nervous | 0.88566081 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.88109610 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.86872406 |
| 122 | MP0000716_abnormal_immune_system | 0.83800328 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.82661230 |
| 124 | MP0002090_abnormal_vision | 0.81050723 |
| 125 | MP0005397_hematopoietic_system_phenotyp | 0.80737160 |
| 126 | MP0001545_abnormal_hematopoietic_system | 0.80737160 |
| 127 | MP0005448_abnormal_energy_balance | 0.79829068 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.79377937 |
| 129 | MP0003045_fibrosis | 0.78145164 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.76609388 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.75029028 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 0.74102361 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.73199081 |
| 134 | MP0004233_abnormal_muscle_weight | 0.72645047 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.72477664 |
| 136 | MP0000367_abnormal_coat/_hair | 0.72427718 |
| 137 | MP0003136_yellow_coat_color | 0.70587900 |
| 138 | MP0009931_abnormal_skin_appearance | 0.70314297 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.70232165 |
| 140 | MP0000627_abnormal_mammary_gland | 0.69798866 |
| 141 | MP0005085_abnormal_gallbladder_physiolo | 0.68468648 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.68073532 |
| 143 | MP0008004_abnormal_stomach_pH | 0.66723680 |
| 144 | MP0002166_altered_tumor_susceptibility | 0.65875005 |
| 145 | MP0003633_abnormal_nervous_system | 0.65460207 |
| 146 | MP0002557_abnormal_social/conspecific_i | 0.65302666 |
| 147 | MP0002163_abnormal_gland_morphology | 0.64413180 |
| 148 | MP0002653_abnormal_ependyma_morphology | 0.63847169 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.63248341 |
| 150 | MP0000678_abnormal_parathyroid_gland | 0.62713712 |
| 151 | MP0003866_abnormal_defecation | 0.61714175 |
| 152 | MP0003172_abnormal_lysosome_physiology | 0.61147937 |
| 153 | MP0003953_abnormal_hormone_level | 0.61004626 |
| 154 | MP0002398_abnormal_bone_marrow | 0.59682289 |
| 155 | MP0005636_abnormal_mineral_homeostasis | 0.59259901 |
| 156 | MP0005381_digestive/alimentary_phenotyp | 0.57855785 |
| 157 | MP0000631_abnormal_neuroendocrine_gland | 0.56522235 |
| 158 | MP0005319_abnormal_enzyme/_coenzyme | 0.56274456 |
| 159 | MP0000955_abnormal_spinal_cord | 0.55970176 |
| 160 | MP0003942_abnormal_urinary_system | 0.52915572 |
| 161 | MP0002089_abnormal_postnatal_growth/wei | 0.49589340 |
| 162 | MP0000432_abnormal_head_morphology | 0.48832943 |
| 163 | MP0000477_abnormal_intestine_morphology | 0.48397798 |
| 164 | MP0002115_abnormal_skeleton_extremities | 0.48357193 |
| 165 | MP0003868_abnormal_feces_composition | 0.46886461 |
| 166 | MP0002118_abnormal_lipid_homeostasis | 0.46490262 |
| 167 | MP0001348_abnormal_lacrimal_gland | 0.46016062 |
| 168 | MP0000920_abnormal_myelination | 0.45643609 |
| 169 | MP0000733_abnormal_muscle_development | 0.45318954 |
| 170 | MP0002111_abnormal_tail_morphology | 0.43378329 |
| 171 | MP0003631_nervous_system_phenotype | 0.41566543 |
| 172 | MP0000470_abnormal_stomach_morphology | 0.39667893 |
| 173 | MP0003936_abnormal_reproductive_system | 0.39595773 |
| 174 | MP0005623_abnormal_meninges_morphology | 0.38571427 |
| 175 | MP0000747_muscle_weakness | 0.37912730 |
| 176 | MP0001731_abnormal_postnatal_growth | 0.37494295 |
| 177 | MP0002088_abnormal_embryonic_growth/wei | 0.36181419 |
| 178 | MP0003984_embryonic_growth_retardation | 0.34570941 |
| 179 | MP0001145_abnormal_male_reproductive | 0.32534304 |
| 180 | MP0001661_extended_life_span | 0.32530016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.18339023 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.87798047 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.44746953 |
| 4 | Abnormality of secondary sexual hair (HP:0009888) | 5.40430713 |
| 5 | Abnormality of the axillary hair (HP:0100134) | 5.40430713 |
| 6 | Abnormality of the 1st metacarpal (HP:0010009) | 5.39951131 |
| 7 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 5.34897392 |
| 8 | Short 1st metacarpal (HP:0010034) | 5.34897392 |
| 9 | Flat acetabular roof (HP:0003180) | 5.22951160 |
| 10 | Testicular atrophy (HP:0000029) | 5.20244712 |
| 11 | Abnormal tarsal ossification (HP:0008369) | 5.16991006 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.96649553 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.78382942 |
| 14 | Thick nail (HP:0001805) | 4.73237201 |
| 15 | Aortic aneurysm (HP:0004942) | 4.65198066 |
| 16 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.62600462 |
| 17 | Ulnar claw (HP:0001178) | 4.60251548 |
| 18 | Broad face (HP:0000283) | 4.57262532 |
| 19 | Amelogenesis imperfecta (HP:0000705) | 4.55432794 |
| 20 | Gonadotropin excess (HP:0000837) | 4.32305464 |
| 21 | Short phalanx of the thumb (HP:0009660) | 4.30168785 |
| 22 | Neoplasm of the heart (HP:0100544) | 4.22877265 |
| 23 | Abnormality of the phalanges of the hallux (HP:0010057) | 4.22007491 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 4.17950547 |
| 25 | Abnormality of carpal bone ossification (HP:0006257) | 4.13975254 |
| 26 | Abnormal foot bone ossification (HP:0010675) | 4.08107746 |
| 27 | Gingivitis (HP:0000230) | 4.03977447 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.96735952 |
| 29 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.96517325 |
| 30 | Parakeratosis (HP:0001036) | 3.90242109 |
| 31 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.87851141 |
| 32 | Stomatitis (HP:0010280) | 3.83288070 |
| 33 | Septate vagina (HP:0001153) | 3.81804589 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.76739031 |
| 35 | Plantar hyperkeratosis (HP:0007556) | 3.72109360 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.65529154 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.62449007 |
| 38 | Increased IgM level (HP:0003496) | 3.56743990 |
| 39 | Abnormal ossification of hand bones (HP:0005921) | 3.54963317 |
| 40 | Abnormal hand bone ossification (HP:0010660) | 3.53504303 |
| 41 | Obstructive lung disease (HP:0006536) | 3.51500539 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 3.51500539 |
| 43 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.51258704 |
| 44 | Malnutrition (HP:0004395) | 3.51159141 |
| 45 | Glomerulonephritis (HP:0000099) | 3.44418042 |
| 46 | Myokymia (HP:0002411) | 3.42222319 |
| 47 | Hypotrichosis (HP:0001006) | 3.41675351 |
| 48 | Increased IgE level (HP:0003212) | 3.38468530 |
| 49 | Prostate neoplasm (HP:0100787) | 3.37004848 |
| 50 | Flattened epiphyses (HP:0003071) | 3.34990138 |
| 51 | Palmoplantar hyperkeratosis (HP:0000972) | 3.32134505 |
| 52 | Sparse lateral eyebrow (HP:0005338) | 3.30031994 |
| 53 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.24931469 |
| 54 | Premature loss of primary teeth (HP:0006323) | 3.23510941 |
| 55 | Vasculitis (HP:0002633) | 3.23306559 |
| 56 | Lip pit (HP:0100267) | 3.20445295 |
| 57 | Recurrent skin infections (HP:0001581) | 3.19410578 |
| 58 | Palmar hyperkeratosis (HP:0010765) | 3.14336302 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07073840 |
| 60 | Nephritis (HP:0000123) | 3.04497324 |
| 61 | Submucous cleft hard palate (HP:0000176) | 3.04204852 |
| 62 | Bronchomalacia (HP:0002780) | 3.02076316 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99238665 |
| 64 | Fragile nails (HP:0001808) | 2.99023873 |
| 65 | Anal stenosis (HP:0002025) | 2.92414443 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.92122473 |
| 67 | Periodontitis (HP:0000704) | 2.89316240 |
| 68 | Aortic dissection (HP:0002647) | 2.85597340 |
| 69 | Onycholysis (HP:0001806) | 2.85555436 |
| 70 | Axonal loss (HP:0003447) | 2.84932200 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.81472885 |
| 72 | Abnormality of the parathyroid morphology (HP:0011766) | 2.79668647 |
| 73 | Partial duplication of thumb phalanx (HP:0009944) | 2.77088973 |
| 74 | Broad metatarsal (HP:0001783) | 2.75362539 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.73674491 |
| 76 | Tetraparesis (HP:0002273) | 2.72105365 |
| 77 | Milia (HP:0001056) | 2.71260120 |
| 78 | Azoospermia (HP:0000027) | 2.71185900 |
| 79 | Optic neuritis (HP:0100653) | 2.70637400 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.70637400 |
| 81 | Bifid scrotum (HP:0000048) | 2.69153650 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.69013783 |
| 83 | Pustule (HP:0200039) | 2.67735193 |
| 84 | Orchitis (HP:0100796) | 2.63624594 |
| 85 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.62581850 |
| 86 | Urticaria (HP:0001025) | 2.62442010 |
| 87 | Fibular aplasia (HP:0002990) | 2.60029365 |
| 88 | Woolly hair (HP:0002224) | 2.51545816 |
| 89 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.50521003 |
| 90 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.47221733 |
| 91 | Xerostomia (HP:0000217) | 2.47038642 |
| 92 | Short nail (HP:0001799) | 2.46713140 |
| 93 | Nail dystrophy (HP:0008404) | 2.46700650 |
| 94 | Intrahepatic cholestasis (HP:0001406) | 2.44417667 |
| 95 | Testicular neoplasm (HP:0010788) | 2.42201557 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40750371 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40750371 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40750371 |
| 99 | Microretrognathia (HP:0000308) | 2.40454159 |
| 100 | Aortic regurgitation (HP:0001659) | 2.39744400 |
| 101 | Dysautonomia (HP:0002459) | 2.38700932 |
| 102 | 11 pairs of ribs (HP:0000878) | 2.35485330 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.35358919 |
| 104 | Erythema (HP:0010783) | 2.34126067 |
| 105 | Abnormal hemoglobin (HP:0011902) | 2.32443060 |
| 106 | Myositis (HP:0100614) | 2.30683331 |
| 107 | Ureteral stenosis (HP:0000071) | 2.30524517 |
| 108 | Sepsis (HP:0100806) | 2.30446657 |
| 109 | Cervical subluxation (HP:0003308) | 2.29309415 |
| 110 | Partial duplication of the phalanx of hand (HP:0009999) | 2.28415557 |
| 111 | Autoimmune hemolytic anemia (HP:0001890) | 2.27694736 |
| 112 | Gangrene (HP:0100758) | 2.25999592 |
| 113 | Ureteral obstruction (HP:0006000) | 2.25737055 |
| 114 | Corneal erosion (HP:0200020) | 2.23314313 |
| 115 | Gaze-evoked nystagmus (HP:0000640) | 2.23111961 |
| 116 | Laryngomalacia (HP:0001601) | 2.21745452 |
| 117 | Abnormality of abdominal situs (HP:0011620) | 2.18769582 |
| 118 | Abdominal situs inversus (HP:0003363) | 2.18769582 |
| 119 | Basal ganglia calcification (HP:0002135) | 2.18544046 |
| 120 | Dysdiadochokinesis (HP:0002075) | 2.18086996 |
| 121 | Popliteal pterygium (HP:0009756) | 2.17943677 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 2.16972625 |
| 123 | Anhidrosis (HP:0000970) | 2.16971204 |
| 124 | Osteomyelitis (HP:0002754) | 2.15724252 |
| 125 | Recurrent pneumonia (HP:0006532) | 2.13571523 |
| 126 | Congenital glaucoma (HP:0001087) | 2.12906339 |
| 127 | Bulbar palsy (HP:0001283) | 2.10603088 |
| 128 | Impaired smooth pursuit (HP:0007772) | 2.10581858 |
| 129 | Abnormality of nail color (HP:0100643) | 2.10316159 |
| 130 | Persistence of primary teeth (HP:0006335) | 2.09889534 |
| 131 | Cellulitis (HP:0100658) | 2.09675596 |
| 132 | Skin ulcer (HP:0200042) | 2.09086272 |
| 133 | Thoracolumbar scoliosis (HP:0002944) | 2.09077696 |
| 134 | Distal arthrogryposis (HP:0005684) | 2.08503233 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 2.07459754 |
| 136 | Severe short stature (HP:0003510) | 2.06955432 |
| 137 | Tracheomalacia (HP:0002779) | 2.06743023 |
| 138 | Pruritus (HP:0000989) | 2.05822575 |
| 139 | Lower limb hyperreflexia (HP:0002395) | 2.05651554 |
| 140 | Aplasia cutis congenita (HP:0001057) | 2.04970509 |
| 141 | Hyperparathyroidism (HP:0000843) | 2.04821116 |
| 142 | Dysmetric saccades (HP:0000641) | 2.04411279 |
| 143 | Urethral obstruction (HP:0000796) | 2.01975739 |
| 144 | Pili torti (HP:0003777) | 2.01784223 |
| 145 | Erythroderma (HP:0001019) | 2.01350674 |
| 146 | Short humerus (HP:0005792) | 1.98721100 |
| 147 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98299926 |
| 148 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98299926 |
| 149 | Alopecia of scalp (HP:0002293) | 1.96481505 |
| 150 | Intention tremor (HP:0002080) | 1.96274536 |
| 151 | Genetic anticipation (HP:0003743) | 1.93695396 |
| 152 | Pulmonary infiltrates (HP:0002113) | 1.93574365 |
| 153 | Gastrointestinal dysmotility (HP:0002579) | 1.92925968 |
| 154 | Germ cell neoplasia (HP:0100728) | 1.92279548 |
| 155 | Osteolytic defects of the hand bones (HP:0009699) | 1.91879201 |
| 156 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91879201 |
| 157 | Distal lower limb muscle weakness (HP:0009053) | 1.91866888 |
| 158 | Bone pain (HP:0002653) | 1.90274172 |
| 159 | Neonatal hypoglycemia (HP:0001998) | 1.89126357 |
| 160 | Hypothermia (HP:0002045) | 1.88805229 |
| 161 | Obstructive sleep apnea (HP:0002870) | 1.88801006 |
| 162 | Meningitis (HP:0001287) | 1.88678015 |
| 163 | Recurrent viral infections (HP:0004429) | 1.86921102 |
| 164 | Shallow orbits (HP:0000586) | 1.84109432 |
| 165 | Cheilitis (HP:0100825) | 1.84001747 |
| 166 | Abnormality of the prostate (HP:0008775) | 1.83869874 |
| 167 | Joint swelling (HP:0001386) | 1.83504687 |
| 168 | Advanced eruption of teeth (HP:0006288) | 1.83178555 |
| 169 | Hyperpituitarism (HP:0010514) | 1.82458092 |
| 170 | Abnormal spermatogenesis (HP:0008669) | 1.82302523 |
| 171 | Aplastic anemia (HP:0001915) | 1.81299690 |
| 172 | Abnormal blistering of the skin (HP:0008066) | 1.81220807 |
| 173 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.80677003 |
| 174 | Atrophic scars (HP:0001075) | 1.79971213 |
| 175 | Short femoral neck (HP:0100864) | 1.78792538 |
| 176 | Skin nodule (HP:0200036) | 1.78539459 |
| 177 | Absent phalangeal crease (HP:0006109) | 1.77429209 |
| 178 | Upper limb muscle weakness (HP:0003484) | 1.77295284 |
| 179 | Overgrowth (HP:0001548) | 1.77223566 |
| 180 | Abnormality of the nasal septum (HP:0000419) | 1.76383772 |
| 181 | Down-sloping shoulders (HP:0200021) | 1.75888248 |
| 182 | Abnormality of the calf musculature (HP:0001430) | 1.75482684 |
| 183 | Recurrent lower respiratory tract infections (HP:0002783) | 1.75171438 |
| 184 | Disinhibition (HP:0000734) | 1.74594310 |
| 185 | Chin dimple (HP:0010751) | 1.74108943 |
| 186 | Narrow palate (HP:0000189) | 1.74056603 |
| 187 | Growth hormone excess (HP:0000845) | 1.73854333 |
| 188 | Short metatarsal (HP:0010743) | 1.72399364 |
| 189 | Stroke (HP:0001297) | 1.70928305 |
| 190 | Right ventricular cardiomyopathy (HP:0011663) | 1.70875392 |
| 191 | Macroorchidism (HP:0000053) | 1.70365982 |
| 192 | Abnormality of the fibula (HP:0002991) | 1.69661513 |
| 193 | Absent hair (HP:0002298) | 1.68170421 |
| 194 | Hypoplastic nipples (HP:0002557) | 1.66886893 |
| 195 | Limb ataxia (HP:0002070) | 1.66399986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 8.37510855 |
| 2 | RIPK4 | 7.53997967 |
| 3 | CAMK1G | 6.47819312 |
| 4 | TAOK1 | 5.42671780 |
| 5 | AKT3 | 4.41641376 |
| 6 | PBK | 4.09895848 |
| 7 | MST1R | 3.92381874 |
| 8 | MAP3K14 | 3.69588887 |
| 9 | BLK | 3.15584460 |
| 10 | EEF2K | 2.86501558 |
| 11 | TRIB3 | 2.65810722 |
| 12 | MARK2 | 2.42479103 |
| 13 | PRKD2 | 2.39056702 |
| 14 | MYLK | 2.38161794 |
| 15 | TBK1 | 2.27026085 |
| 16 | MST4 | 2.19106430 |
| 17 | IRAK4 | 2.03322947 |
| 18 | IRAK3 | 2.02082400 |
| 19 | TYK2 | 1.94939519 |
| 20 | EPHA3 | 1.89090703 |
| 21 | JAK3 | 1.86828735 |
| 22 | YES1 | 1.80760222 |
| 23 | MARK3 | 1.79423124 |
| 24 | IKBKE | 1.76999413 |
| 25 | TXK | 1.75250157 |
| 26 | JAK1 | 1.69716667 |
| 27 | IKBKB | 1.67734329 |
| 28 | MATK | 1.59483725 |
| 29 | MAP3K2 | 1.51499077 |
| 30 | SIK3 | 1.50082181 |
| 31 | NTRK1 | 1.42356435 |
| 32 | PRKD3 | 1.38324147 |
| 33 | PIM2 | 1.37834569 |
| 34 | PAK2 | 1.36387135 |
| 35 | BMPR2 | 1.36215752 |
| 36 | MAP3K13 | 1.35534994 |
| 37 | TESK2 | 1.33972857 |
| 38 | TRPM7 | 1.31729468 |
| 39 | KSR2 | 1.30930988 |
| 40 | CDK12 | 1.30904054 |
| 41 | SGK494 | 1.29229826 |
| 42 | SGK223 | 1.29229826 |
| 43 | SMG1 | 1.28692643 |
| 44 | PRKCI | 1.27724693 |
| 45 | FGFR3 | 1.27437313 |
| 46 | BMPR1B | 1.20602142 |
| 47 | MET | 1.18886059 |
| 48 | CAMK1 | 1.15500878 |
| 49 | EPHB1 | 1.15369523 |
| 50 | FGFR4 | 1.09466032 |
| 51 | MTOR | 1.07555550 |
| 52 | ARAF | 1.02802255 |
| 53 | BMX | 1.00504582 |
| 54 | MAP3K12 | 1.00244491 |
| 55 | CDC42BPA | 1.00075845 |
| 56 | MAP3K9 | 0.99300939 |
| 57 | IRAK1 | 0.97467918 |
| 58 | PRKAA2 | 0.96779840 |
| 59 | IRAK2 | 0.96722057 |
| 60 | MAPKAPK3 | 0.91734916 |
| 61 | MAP3K1 | 0.91616492 |
| 62 | ADRBK2 | 0.89068469 |
| 63 | GRK5 | 0.88517463 |
| 64 | JAK2 | 0.87151780 |
| 65 | EPHB2 | 0.86423946 |
| 66 | NEK9 | 0.84998912 |
| 67 | ERBB3 | 0.84790079 |
| 68 | PKN2 | 0.84515870 |
| 69 | RET | 0.83493430 |
| 70 | SIK1 | 0.83206941 |
| 71 | CHUK | 0.80950261 |
| 72 | PRKAA1 | 0.80156288 |
| 73 | ACVR1B | 0.78850852 |
| 74 | SGK2 | 0.78143808 |
| 75 | RAF1 | 0.77883958 |
| 76 | SYK | 0.75521421 |
| 77 | LIMK1 | 0.74965402 |
| 78 | FER | 0.74952705 |
| 79 | LCK | 0.74925129 |
| 80 | PRKCD | 0.72525268 |
| 81 | RPS6KA2 | 0.71262760 |
| 82 | SGK3 | 0.70923984 |
| 83 | CSK | 0.70843050 |
| 84 | LYN | 0.70704078 |
| 85 | HCK | 0.69788926 |
| 86 | DAPK2 | 0.69405421 |
| 87 | DMPK | 0.69205108 |
| 88 | ZAP70 | 0.67096927 |
| 89 | PRKCE | 0.66895466 |
| 90 | STK39 | 0.65589319 |
| 91 | EIF2AK2 | 0.63477610 |
| 92 | GSK3A | 0.60324013 |
| 93 | ABL2 | 0.59823980 |
| 94 | LMTK2 | 0.59650409 |
| 95 | NLK | 0.59517710 |
| 96 | WNK1 | 0.59123155 |
| 97 | ERBB4 | 0.59021366 |
| 98 | ICK | 0.58159654 |
| 99 | MAP4K1 | 0.57692665 |
| 100 | MAPKAPK5 | 0.56673655 |
| 101 | MAP2K1 | 0.56449253 |
| 102 | BRAF | 0.53653842 |
| 103 | ADRBK1 | 0.51992910 |
| 104 | MAP3K11 | 0.51704856 |
| 105 | PIM1 | 0.50507348 |
| 106 | STK24 | 0.49858925 |
| 107 | PDPK1 | 0.49620755 |
| 108 | MAP2K2 | 0.49564574 |
| 109 | WNK4 | 0.47916569 |
| 110 | CAMKK2 | 0.47736859 |
| 111 | ABL1 | 0.47107825 |
| 112 | STK11 | 0.46840269 |
| 113 | BCR | 0.46128641 |
| 114 | MAP3K5 | 0.45809401 |
| 115 | MAP3K3 | 0.43684537 |
| 116 | TAOK3 | 0.43624211 |
| 117 | CAMKK1 | 0.43568694 |
| 118 | FGR | 0.43268494 |
| 119 | MAPKAPK2 | 0.43029514 |
| 120 | ERN1 | 0.42865423 |
| 121 | PRKCZ | 0.42021084 |
| 122 | BTK | 0.41998092 |
| 123 | LATS1 | 0.41967970 |
| 124 | FRK | 0.40834845 |
| 125 | KIT | 0.40070721 |
| 126 | PDK1 | 0.39999404 |
| 127 | SCYL2 | 0.39935448 |
| 128 | NME2 | 0.37845248 |
| 129 | TEC | 0.37023074 |
| 130 | PRKD1 | 0.36466160 |
| 131 | PIK3CG | 0.35627764 |
| 132 | TESK1 | 0.35380165 |
| 133 | PRKCQ | 0.34423024 |
| 134 | PDGFRB | 0.33760547 |
| 135 | IGF1R | 0.33558664 |
| 136 | SGK1 | 0.33130913 |
| 137 | RPS6KA4 | 0.32509142 |
| 138 | PRKG2 | 0.32330751 |
| 139 | STK4 | 0.31410657 |
| 140 | BRD4 | 0.27794129 |
| 141 | PAK3 | 0.27025347 |
| 142 | STK38 | 0.26853832 |
| 143 | ERBB2 | 0.25354518 |
| 144 | CAMK4 | 0.25276579 |
| 145 | FYN | 0.24099345 |
| 146 | GSK3B | 0.23137334 |
| 147 | LRRK2 | 0.22183574 |
| 148 | MAPK8 | 0.21821142 |
| 149 | TNK2 | 0.21755123 |
| 150 | MINK1 | 0.20764204 |
| 151 | MAPK10 | 0.18700748 |
| 152 | ILK | 0.17943161 |
| 153 | MAP3K7 | 0.16216171 |
| 154 | MAPK1 | 0.15322629 |
| 155 | AKT1 | 0.15246563 |
| 156 | DAPK3 | 0.14962650 |
| 157 | CDK7 | 0.13206806 |
| 158 | MAPK14 | 0.12257452 |
| 159 | DDR2 | 0.11992828 |
| 160 | TGFBR2 | 0.11115666 |
| 161 | STK38L | 0.10314347 |
| 162 | EPHA2 | 0.09877997 |
| 163 | HIPK2 | 0.09223017 |
| 164 | TTN | 0.08703581 |
| 165 | GRK7 | 0.08356456 |
| 166 | RPS6KA3 | 0.06897014 |
| 167 | CAMK2G | 0.04351592 |
| 168 | CDK1 | 0.04095572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 8.95786269 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.82642825 |
| 3 | Prostate cancer_Homo sapiens_hsa05215 | 3.18703945 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90124780 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.76775265 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74644129 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.48601724 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.43120285 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.39899854 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37578486 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.37375769 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.34486005 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20946967 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.20361848 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 2.16583274 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02098151 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98958257 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.93652898 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.92445042 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.88372700 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.88248814 |
| 22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.86693047 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.85021183 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84486908 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72518639 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66047755 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.66022114 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.64833045 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61746067 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.60632505 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53882917 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.50579331 |
| 33 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.42569716 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41590675 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40390633 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38391041 |
| 37 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.36484603 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.32987633 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32636625 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31122630 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30473283 |
| 42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29409516 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.26861637 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.25524318 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23683460 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.22841747 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20642440 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20204208 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19964465 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.19183486 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.18359680 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.16334584 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15779663 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 1.14488608 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11820788 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10993399 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09551306 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09492268 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01244343 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00564460 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00510619 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99566660 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99204391 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97717748 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.96302520 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.96024155 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95710527 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94119500 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.94095872 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93938732 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.93678981 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92710680 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91833248 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.91287270 |
| 75 | Tight junction_Homo sapiens_hsa04530 | 0.90230680 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89923509 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88798486 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88731553 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.88017268 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87618372 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.86825739 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86706559 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86670275 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86648756 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85325209 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.83465698 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83288840 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81474901 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79783789 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79260627 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77874516 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77335784 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.76494275 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75880344 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.75436712 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75387909 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74539863 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73797994 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73718222 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.72533578 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71626871 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71608634 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71295945 |
| 104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69834683 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68932001 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68377055 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66687052 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66248998 |
| 109 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65410890 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62094843 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60632514 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60319400 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60121507 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58584805 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58396378 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.57803027 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57159473 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56887396 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56399691 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54830064 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54152209 |
| 122 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53755096 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53517066 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51841765 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49664834 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49077362 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48091372 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48040426 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47958563 |
| 130 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45869397 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44701379 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42795756 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42304267 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41420406 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41121987 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39559961 |
| 137 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38463961 |
| 138 | Gap junction_Homo sapiens_hsa04540 | 0.38283182 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.38166665 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.38029663 |
| 141 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36633437 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36118842 |
| 143 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36026909 |
| 144 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35943740 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.35832436 |
| 146 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35384750 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35011235 |
| 148 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34389807 |
| 149 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33972650 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32983785 |
| 151 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32302653 |
| 152 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31459913 |
| 153 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29639203 |
| 154 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29195650 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28956225 |
| 156 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28943991 |
| 157 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28767227 |
| 158 | Focal adhesion_Homo sapiens_hsa04510 | 0.28281223 |
| 159 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.28136091 |
| 160 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27782168 |
| 161 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26898796 |
| 162 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25564226 |
| 163 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24624263 |
| 164 | Bladder cancer_Homo sapiens_hsa05219 | 0.24315490 |
| 165 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23976566 |
| 166 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23711889 |
| 167 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22575687 |
| 168 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21800587 |
| 169 | Endocytosis_Homo sapiens_hsa04144 | 0.21770394 |
| 170 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21301281 |
| 171 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20857062 |
| 172 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20805489 |
| 173 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20377572 |
| 174 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20031376 |

